Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade

Z. Vernerová, P. Kujal, H. J. Kramer, A. Bäcker, L. Červenka, I. Vaněčková

. 2009 ; 58 (Suppl. 2) : S69 - S78.
. 2009 ; 58 (Suppl. 2) : S69 - S78.

Language English Country Czech Republic

Document type Review

Renin-angiotensin system (RAS) plays a key role in the regulation of renal function, volume of extracellular fluid and blood pressure. The activation of RAS also induces oxidative stress, particularly superoxide anion (O(2)(-)) formation. Although the involvement of O(2)(-) production in the pathology of many diseases is known for long, recent studies also strongly suggest its physiological regulatory function of many organs including the kidney. However, a marked accumulation of O(2)(-) in the kidney alters normal regulation of renal function and thus may contribute to the development of salt-sensitivity and hypertension. In the kidney, O(2)(-) acts as vasoconstrictor and enhances tubular sodium reabsorption. Nitric oxide (NO), another important radical that exhibits opposite effects than O(2)(-), is also involved in the regulation of kidney function. O(2)(-) rapidly interacts with NO and thus, when O(2)(-) production increases, it diminishes the bioavailability of NO leading to the impairment of organ function. As the activation of RAS, particularly the enhanced production of angiotensin II, can induce both O(2)(-) and NO generation, it has been suggested that physiological interactions of RAS, NO and O(2)(-) provide a coordinated regulation of kidney function. The imbalance of these interactions is critically linked to the pathophysiology of salt-sensitivity and hypertension.

References provided by Crossref.org

Bibliography, etc.

Lit.: 35

000      
00000naa 2200000 a 4500
001      
bmc10013405
003      
CZ-PrNML
005      
20151006141143.0
008      
100604s2009 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.931640 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Vernerová, Zdenka, $d 1960-2020 $7 jo2002104672
245    10
$a End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade / $c Z. Vernerová, P. Kujal, H. J. Kramer, A. Bäcker, L. Červenka, I. Vaněčková
314    __
$a Center for Cardiovascular Research, Prague likp@ikem.cz
504    __
$a Lit.: 35
520    9_
$a Renin-angiotensin system (RAS) plays a key role in the regulation of renal function, volume of extracellular fluid and blood pressure. The activation of RAS also induces oxidative stress, particularly superoxide anion (O(2)(-)) formation. Although the involvement of O(2)(-) production in the pathology of many diseases is known for long, recent studies also strongly suggest its physiological regulatory function of many organs including the kidney. However, a marked accumulation of O(2)(-) in the kidney alters normal regulation of renal function and thus may contribute to the development of salt-sensitivity and hypertension. In the kidney, O(2)(-) acts as vasoconstrictor and enhances tubular sodium reabsorption. Nitric oxide (NO), another important radical that exhibits opposite effects than O(2)(-), is also involved in the regulation of kidney function. O(2)(-) rapidly interacts with NO and thus, when O(2)(-) production increases, it diminishes the bioavailability of NO leading to the impairment of organ function. As the activation of RAS, particularly the enhanced production of angiotensin II, can induce both O(2)(-) and NO generation, it has been suggested that physiological interactions of RAS, NO and O(2)(-) provide a coordinated regulation of kidney function. The imbalance of these interactions is critically linked to the pathophysiology of salt-sensitivity and hypertension.
650    _2
$a financování organizované $7 D005381
650    _2
$a angiotensin II $x metabolismus $7 D000804
650    _2
$a zvířata $7 D000818
650    _2
$a krevní tlak $7 D001794
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x etiologie $x metabolismus $x patofyziologie $7 D006973
650    _2
$a ledviny $x metabolismus $x patofyziologie $7 D007668
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a oxidační stres $7 D018384
650    _2
$a renin-angiotensin systém $7 D012084
650    _2
$a sodík $x metabolismus $7 D012964
650    _2
$a kuchyňská sůl $x škodlivé účinky $7 D017673
650    _2
$a superoxidy $x metabolismus $7 D013481
655    _2
$a přehledy $7 D016454
700    1_
$a Kujal, Petr. $7 xx0244311
700    1_
$a Kramer, Herbert J. $7 xx0085908
700    1_
$a Bäcker, Angela $7 xx0085909
700    1_
$a Červenka, Luděk, $d 1967- $7 xx0037105
700    1_
$a Vaněčková, Ivana, $d 1964- $7 xx0030586
773    0_
$w MED00003824 $t Physiological research $g Roč. 58,Suppl. 2 (2009), s. S69 - S78 $x 0862-8408
773    0_
$t Center for cardiovascular research $g Roč. 58,Suppl. 2 (2009), s. S69 - S78 $w MED00173857
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/58%20Suppl%202/58_S69.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 8 $z 0
990    __
$a 20100603155515 $b ABA008
991    __
$a 20151006141328 $b ABA008
999    __
$a ok $b bmc $g 749266 $s 612906
BAS    __
$a 3
BMC    __
$a 2009 $b 58 $c Suppl. 2 $d S69 - S78 $m Physiological research $x MED00003824
BMC    __
$a 2009 $b 58 $c Suppl. 2 $d S69 - S78 $m Center for cardiovascular research $x MED00173857
LZP    __
$a 2010-15/mkme

Find record

Citation metrics

Loading data ...